menu

Our Media Partners

JackLeckerman Company is dedicated to increasing access to medicines in Latin America by fostering collaboration between government officials and the pharmaceutical industry. As a leading business event organizer, JL specializes in global summits, strategic conferences, open forums, and professional training programs for the pharmaceutical and biotechnology sectors across Europe, North America, and Latin America.
Our forums focus on promoting the development and accessibility of biosimilars, addressing critical industry topics, facilitating knowledge exchange, and encouraging strategic discussions. In 2025, JackLeckerman will host several Biosimilars LatAm forums to support mission:

Biosimilars LatAm - Colombia 2025, In-person Forum in Bogota on April 8

https://jackleckerman.com/events/biosimilars-latam-colombia-2025/

Biosimilars LatAm - Brazil 2025, In-person Forum in Sao Paulo on August 13-14

https://jackleckerman.com/events/biosimilars-latam-brazil-2025/

Biosimilars LatAm - Mexico 2025, In-person Forum in Mexico City on November 12-13

https://jackleckerman.com/events/biosimilars-latam-mexico-2025/

Biosimilars LatAm - Global 2026, Online Forum in the 2nd week of March

https://jackleckerman.com/events/biosimilars-latam-global-2026/

Generics and Biosimilars Initiative (GaBI) was founded in 2008. GaBI aims to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care.

The objective of GaBI is to raise the scientific status of generic and biosimilar medicines, via well-documented and up-to-date information about generic and biosimilar medicines both in print (www.gabi-journal.net) and electronically (www.gabionline.net) in an open access format, providing high quality, scientifically sound and reliable information to healthcare professionals including physicians, pharmacists and nurses, consumers, drug developers, third-party payers, legislators and assessors; who are in need of a reliable, critical and independent source of information on all aspects of generic and biosimilar medicines.

Subscribe to gain easy access of information on the latest scientific research and developments in generic and biosimilar medicines via GaBI Online to editorial@gabionline.net; or submit a manuscript to GaBI Journal to editorial@gabi-journal.net.

GaBI’s mission – Building trust in cost-effective treatments

The Global Generics and Biosimilar Awards celebrate the greatest achievements and innovations across the development, authorisation, marketing and distribution of global, off-patent pharmaceuticals. These illustrious awards provide a unique opportunity for the industry to come together to discuss future opportunities and challenges and shine a light on the companies and individuals driving positive change. Winners will be recognised across a range of categories, including Biosimilar Initiative of the Year, Leader of the Year, API Supplier of the Year and more.

Find out more about the awards here: https://www.citeline.com/awards/ggbawards

The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to improve patient outcomes. Discussions include the current landscape for advanced health care management – reviewing emerging treatment paradigms, approaches and considerations – all by authoritative industry voices.

Biosimilars review & Report (BR&R) provides education, commentary and updates on the biosimilar marketplace. Visit https://biosimilarsrr.com/ for a frequently updated resource on the entire field, including biosimilar product profiles, approvals and policy and coverage decisions. We publish regular blogs you can subscribe to receive notifications of new posts by email.

A unique organization, American Conference Institute (ACI) is devoted to providing the business intelligence that senior decision-makers need to respond to challenges around the world. Staffed by industry specialists, lawyers and other professionals, ACI operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge. To learn more about our event offerings, click here.

CONTACT US
IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION
C/O DYN SA - Rue de Cornavin 11 - 1201 Geneva, Switzerland